SLONIN JONATHAN
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to SLONIN JONATHAN. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PCRX | Chief Medical Officer | Sale | 3,960 | $24.09 | $95,396 | Nov 17, 2025 |
| PCRX | Chief Medical Officer | Tax Withholding | 315 | $22.07 | $6,952 | Aug 1, 2025 |
| PCRX | Chief Medical Officer | Tax Withholding | 5,084 | $26.40 | $134,218 | Jun 3, 2025 |
| PCRX | Chief Medical Officer | Award / Grant | 93,600 | — | — | Feb 1, 2025 |
| PCRX | Chief Medical Officer | Tax Withholding | 371 | $18.33 | $6,800 | Jan 6, 2025 |
| PCRX | Chief Medical Officer | Tax Withholding | 305 | $20.75 | $6,329 | Aug 2, 2024 |
| PCRX | Chief Medical Officer | Award / Grant | 437 | $24.32 | $10,634 | Jul 1, 2024 |
| PCRX | Chief Medical Officer | Award / Grant | 54,300 | — | — | Jun 11, 2024 |
| PCRX | Chief Medical Officer | Tax Withholding | 1,615 | $30.89 | $49,887 | Jun 3, 2024 |
| PCRX | Chief Medical Officer | Award / Grant | 5,000 | — | — | Jan 2, 2024 |
| PCRX | Chief Clinical Officer | Sale | 490 | $37.87 | $18,556 | Jun 6, 2023 |
| PCRX | Chief Clinical Officer | Sale | 308 | $55.70 | $17,156 | Aug 3, 2022 |
| PCRX | Chief Clinical Officer | Sale | 924 | $57.19 | $52,844 | Jul 5, 2022 |
| PCRX | Chief Clinical Officer | Sale | 362 | $61.37 | $22,216 | Jun 8, 2022 |
| PCRX | Chief Clinical Officer | Option Exercise | 2,000 | $52.37 | $104,740 | May 23, 2022 |
| PCRX | Chief Clinical Officer | Award / Grant | 5,000 | — | — | Aug 3, 2021 |